Search Results - "Tassone, Daniel"

Refine Results
  1. 1

    Pregabalin: A novel γ-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders by Tassone, Daniel M., PharmD, Boyce, Eric, PharmD, Guyer, Jennifer, PharmD, Nuzum, Donald, PharmD

    Published in Clinical therapeutics (2007)
    “…Abstract Background: The US Food and Drug Administration (FDA) approved pregabalin in December 2004 for the treatment of neuropathic pain associated with…”
    Get full text
    Journal Article
  2. 2

    Immunosuppression as a risk factor for COVID‐19: a meta‐analysis by Tassone, Daniel, Thompson, Alexander, Connell, William, Lee, Tanya, Ungaro, Ryan, An, Ping, Ding, Yijuan, Ding, Nik S.

    Published in Internal medicine journal (01-02-2021)
    “…Background While immunosuppression poses a theoretical increase in the risk of COVID‐19, the nature of this relationship is yet to be ascertained. Aims To…”
    Get full text
    Journal Article
  3. 3

    Prospective audit and feedback of Clostridioides difficile PCR at the time of ordering increases appropriateness of testing by Tassone, Daniel, Hitchcock, Matthew, Markley, John, Stevens, Michael

    “…Background: Over-testing for Clostridioides difficile infection outside acute diarrheal illness without a clear alternative cause can lead to inappropriate…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study by Hanrahan, Timothy P., Chan, Robbie, Tassone, Daniel, Ding, Nik S., Basnayake, Chamara, Schulberg, Julien, Vasudevan, Abhinav, Kamm, Michael, De Gregorio, Michael, van Langenberg, Daniel R., Niewiadomski, Ola

    Published in Future pharmacology (01-12-2022)
    “…Background: Despite proven efficacy of biologics in inflammatory bowel disease (IBD), many exhibit primary non-response or secondary loss of response and…”
    Get full text
    Journal Article
  6. 6

    Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic by Ghaswalla, Parinaz K, Harpe, Spencer E, Tassone, Daniel, Slattum, Patricia W

    “…Several classes of drugs, such as antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras by Tassone, Daniel, Hartley, Imogen, Ding, Nik Sheng

    Published in Alimentary pharmacology & therapeutics (01-03-2024)
    “…LINKED CONTENT This article is linked to Gonczi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17836 and…”
    Get full text
    Journal Article
  9. 9

    Systematic review and meta‐analysis of endoscopic versus medical management of peptic ulcers with adherent clots by Tassone, Daniel, Kazi, Shamsul, Lee, Tanya, Gilmore, Robert, Ding, Nik

    Published in Journal of gastroenterology and hepatology (01-10-2024)
    “…Peptic ulcer disease is an important cause of upper gastrointestinal bleeding. Current guidelines recommend endoscopic treatment for ulcers with active…”
    Get full text
    Journal Article
  10. 10

    Letter: Muscle thickness measurement using ultrasound-A step closer to the use of body composition analysis in the management of inflammatory bowel disease by Tassone, Daniel, Hartley, Imogen, Ding, Nik Sheng

    Published in Alimentary pharmacology & therapeutics (01-10-2023)
    “…LINKED CONTENT This article is linked to Nguyen et al paper. To view this article, visit https://doi.org/10.1111/apt.17607…”
    Get full text
    Journal Article
  11. 11

    Letter: Combatting sarcopenia to improve clinical outcomes in inflammatory bowel disease by Tassone, Daniel, Hartley, Imogen, Ding, Nik Sheng

    Published in Alimentary pharmacology & therapeutics (01-08-2023)
    “…LINKED CONTENT This article is linked to Gold et al paper. To view this article, visit https://doi.org/10.1111/apt.17498…”
    Get full text
    Journal Article
  12. 12

    Letter: tofacitinib in the real world – do clinical trial data stand up? by Gilmore, Robert, Tassone, Daniel, Ding, Nik S.

    Published in Alimentary pharmacology & therapeutics (01-03-2023)
    “…LINKED CONTENT This article is linked to Straatmijer et al paper. To view this article, visit https://doi.org/10.1111/apt.17248…”
    Get full text
    Journal Article
  13. 13

    Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib by Tassone, Daniel, Singh, Siddharth, Sheng Ding, Nik

    Published in Alimentary pharmacology & therapeutics (01-07-2021)
    “…LINKED CONTENT This article is linked to Farraye et al paper. To view this article, visit https://doi.org/10.1111/apt.16439…”
    Get full text
    Journal Article
  14. 14

    Letter: diagnostic delay in inflammatory bowel disease by Tassone, Daniel, Gilmore, Robert, Lee, Tanya, Ding, Nik S.

    Published in Alimentary pharmacology & therapeutics (01-05-2023)
    “…LINKED CONTENT This article is linked to Jayasooriya et al papers. To view these articles, visit https://doi.org/10.1111/apt.17370 and…”
    Get full text
    Journal Article
  15. 15

    Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE) by Tran, Ai Phuong, Tassone, Daniel, Nossent, Johannes, Ding, Nik Sheng

    Published in Rheumatic & musculoskeletal diseases open (01-05-2022)
    “…To assess the antibody response to disease-modifying antirheumatic drug (DMARD) therapy after the first and second dose of the ChAdOx1nCov-19 (AstraZeneca…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease by Ding, Nik Sheng, Tassone, Daniel, Al Bakir, Ibrahim, Wu, Kyle, Thompson, Alexander J, Connell, William R, Malietzis, George, Lung, Phillip, Singh, Siddharth, Choi, Chang-ho Ryan, Gabe, Simon, Jenkins, John T, Hart, Ailsa

    Published in Journal of Crohn's and colitis (08-09-2022)
    “…Abstract Background and Aims Alterations in body composition are common in inflammatory bowel disease [IBD] and have been associated with differences in…”
    Get full text
    Journal Article
  19. 19

    Implementation of Two-Step Clostridioides difficile Testing Algorithm and Management of Possible Carriers by Markley, J. Daniel, Tassone, Daniel, Christian, Melanie, Vaughan, Leroy, Stevens, Michael P., Hitchcock, Matthew M., Hill, Emily

    “…Background: Updated IDSA-SHEA guidelines recommend different diagnostic approaches to C. difficile depending on whether There are pre-agreed institutional…”
    Get full text
    Journal Article
  20. 20